FDA's generic drug enforcement and approval process :
hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
Description
Viewability
Item Link | Original Source |
---|---|
Full view 4.En 2/3:102-77 | Pennsylvania State University |